1. SP and KLF Transcription Factors in Digestive Physiology and Diseases
    Chang-Kyung Kim et al, 2017, Gastroenterology CrossRef
  2. miR-152-3p Affects the Progression of Colon Cancer via the KLF4/IFITM3 Axis
    Xiaoyi Zhu et al, 2020, Computational and Mathematical Methods in Medicine CrossRef
  3. KLF4 transcription factor in tumorigenesis
    Zhihong He et al, 2023, Cell Death Discovery CrossRef
  4. Mechanism of KLF4 Protection against Acute Liver Injury via Inhibition of Apelin Signaling
    Weitao Ji et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
  5. Peroxisome Proliferator-Activated Receptor γ Expression Is Inversely Associated with Macroscopic Vascular Invasion in Human Hepatocellular Carcinoma
    Hui-Tzu Hsu et al, 2016, International Journal of Molecular Sciences CrossRef
  6. Expression of Vav3 protein and its prognostic value in patients with gastric cancer
    Bibo Tan et al, 2017, Pathology - Research and Practice CrossRef
  7. CRISPR-ON-Mediated KLF4 overexpression inhibits the proliferation, migration and invasion of urothelial bladder cancer in vitro and in vivo
    Xin Xu et al, 2017, Oncotarget CrossRef
  8. Radiation and Stemness Phenotype May Influence Individual Breast Cancer Outcomes: The Crucial Role of MMPs and Microenvironment
    María Auxiliadora Olivares-Urbano et al, 2019, Cancers CrossRef
  9. miR‐148‐3p and miR‐152‐3p synergistically regulate prostate cancer progression via repressing KLF4
    Feng Feng et al, 2019, Journal of Cellular Biochemistry CrossRef
  10. Kruppel-like factor 4 (KLF-4) inhibits the epithelial-to-mesenchymal transition and proliferation of human endometrial carcinoma cells
    Xiaoli Wang et al, 2016, Gynecological Endocrinology CrossRef
  11. RYBP Expression Is Regulated by KLF4 and Sp1 and Is Related to Hepatocellular Carcinoma Prognosis
    Qiaojiajie Zhao et al, 2017, Journal of Biological Chemistry CrossRef
  12. Quantitative proteomic analysis reveals that Luks-PV exerts antitumor activity by regulating the key proteins and metabolic pathways in HepG2 cells
    Chang-Cheng Zhao et al, 2020, Anti-Cancer Drugs CrossRef
  13. Metabolic Reprogramming in Response to Alterations of Mitochondrial DNA and Mitochondrial Dysfunction in Gastric Adenocarcinoma
    Tzu-Ching Chang et al, 2022, International Journal of Molecular Sciences CrossRef
  14. Suppression of epithelial-mesenchymal transition in hepatocellular carcinoma cells by Krüppel-like factor 4
    Qi Li et al, 2016, Oncotarget CrossRef